Cash & Short-Term Investments

$7.69B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$11.59Bperiod endingDec 31, 2025

NVS FY Cash & Short-Term Investments ($9.69B → $11.59B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

NVS cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	11,590,020,000
Dec 31, 2024	13,351,000,000
Dec 31, 2023	13,962,000,000
Dec 31, 2022	18,615,000,000
Dec 31, 2021	28,113,000,000
Dec 31, 2020	11,563,000,000
Dec 31, 2019	11,445,950,530
Dec 31, 2018	15,964,000,000
Dec 31, 2017	9,485,000,000
Dec 31, 2016	7,777,000,000
Dec 31, 2015	5,447,000,000
Dec 31, 2014	13,862,000,000
Dec 31, 2013	9,222,000,000
Dec 31, 2012	8,119,000,000
Dec 31, 2011	5,075,000,000
Dec 31, 2010	8,134,000,000
Dec 31, 2009	17,449,000,000
Dec 31, 2008	6,117,000,000
Dec 31, 2007	13,201,000,000
Dec 31, 2006	7,955,000,000
Dec 31, 2005	10,933,000,000
Dec 31, 2004	14,593,000,000
Dec 31, 2003	13,259,000,000
Dec 31, 2002	12,575,000,000
Dec 31, 2001	13,183,000,000
Dec 31, 2000	12,514,000,000
Dec 31, 1999	10,269,000,000
Dec 31, 1998	9,691,860,465